查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087757

醫療保健領域的虛擬實境市場：按組件、產品類型、交付方式、應用和最終用戶分類－2026-2032年全球市場預測

Virtual Reality in Healthcare Market by Component, Product Type, Delivery Mode, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫療領域的虛擬實境 (VR) 市場將成長至 138 億美元，複合年成長率為 13.18%。

主要市場統計數據
基準年 2025 58億美元
預計年份：2026年 65.4億美元
預測年份 2032 138億美元
複合年成長率 (%) 13.18%

虛擬實境技術在醫療保健領域的應用正從創新試點計畫走向成熟的臨床、培訓和營運流程。醫院、醫學院、復健中心和數位健康開發公司正在利用身臨其境型醫療平台進行疼痛管理、暴露療法、手術規劃、物理復健、臨床醫生培訓和病患教育。推動這項應用普及的因素包括：更有力的臨床證據不斷湧現、頭戴式設備成本降低、空間運算能力提升以及對可擴展臨床功能日益成長的需求。

短期來看，虛擬實境技術應用最迅速的領域是那些能夠解決醫療保健系統實際限制的領域。具體而言，這些領域包括訓練有素的醫護人員短缺、對可重複模擬的需求、慢性疼痛管理、緩解焦慮、中風和肌肉骨骼康復，以及遠端醫療。 AppliedVR公司的RelieVRx是一種用於治療慢性下背痛的藥物，已獲得美國FDA批准，這標誌著處方箋身臨其境型療法監管領域的一個重要里程碑。同時，手術視覺化和模擬平台在手術規劃和醫學教育領域也持續廣泛應用。

對醫療保健管理者而言，虛擬實境的策略價值在於其能夠將標準化、個人化和可衡量的參與度結合。當與臨床管治、資料保護、感染控制規程、無障礙標準和工作流程整合相結合時，虛擬實境可以提高訓練的一致性，擴大治療性介入的覆蓋範圍，並在整個護理過程中創造差異化的患者體驗。

VR醫學領域的變革性變化

隨著數位療法、空間運算、遠端醫療和基於類比的教育的融合，虛擬實境（VR）醫學領域正在重新定義。醫療服務提供者正逐漸擺脫以娛樂為導向的VR，轉而優先考慮那些能夠支援臨床檢驗、互通性、病患安全和可衡量療效的平台。這種轉變正在加速對實證VR療法、身臨其境型醫學模擬以及在臨床醫生指導下進行的復健工具的需求。

人工智慧對醫療虛擬實境的累積影響

人工智慧 (AI) 透過增強身臨其境型體驗的適應性、可衡量性和擴充性，正在拓展虛擬實境在醫療領域的臨床和營運價值。 AI 驅動的 VR 可以個人化治療強度，根據患者表現調整復健訓練，分析使用者動作，並透過患者參與和進展數據來支持臨床決策。在培訓環境中，AI 可以產生逼真的病例變體，評估操作流程，並為學習者提供即時回饋。

區域層面關於醫療虛擬實境技術應用的重要見解

亞太地區是醫療保健領域虛擬實境技術應用最活躍的地區之一。這主要得益於日本人口老化加劇、中國大力投資智慧醫院和數位醫療、印度對大規模醫療保健服務的需求、韓國在數位醫療政策方面的強勁發展勢頭以及澳洲在遠距遠端醫療的成熟應用。在該地區，虛擬實境技術在復健、醫護人員培訓、遠距醫療、認知健康維護和手術模擬等領域應用最為廣泛，但各國在本地化程度、保險報銷政策和監管要求等方面存在顯著差異。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

由於東協地區醫院網路不斷擴展、醫療旅遊蓬勃發展、數位化醫療政策不斷完善以及年輕的科技人才儲備，該地區的虛擬實境技術在醫療保健領域的重要性日益凸顯。儘管新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國的虛擬實境技術應用程度不盡相同，但通用的應用領域包括臨床培訓、病患教育、復健和遠距專家支援。身臨其境型模擬技術在能夠彌補經驗豐富指導員資源匱乏的領域尤其具有巨大潛力。

各國對虛擬實境在醫療領域的應用洞察

美國是該領域最具影響力的國家，這得益於FDA在數位健康領域的積極舉措、大規模的醫療保健系統創新預算，以及虛擬實境技術在疼痛管理、行為醫學、手術規劃和醫學模擬等領域的應用。加拿大正透過復健、學術研究和本地醫療保健模式取得進展，而墨西哥則透過私立醫院、醫學教育和具成本效益的專科醫生培訓來推動需求。巴西大規模的醫院網路、不斷發展的醫療保健技術生態系統以及透過《巴西通用資料保護法》（LGPD）對資料保護的監管重點，在拉丁美洲引領著這一潛力。

為行業領導者提供的實用建議

產業領導者在擴大企業級部署規模之前，應優先考慮經過臨床檢驗的應用案例。疼痛管理、復原、焦慮緩解、手術規劃和醫學模擬等領域，相較於定義廣泛的健康應用，能夠提供更清晰的證據支持。供應商應建立臨床研究項目，公佈研究結果，並根據醫療服務提供者的工作流程客製化產品藍圖，而不是僅依靠新穎性來吸引使用者。

調查方法

本執行摘要是基於對同行評審醫學文獻、監管資料庫、政府衛生機構、公共衛生資料集和檢驗的公共資訊的二手研究。資訊來源包括美國食品藥物管理局（FDA）的數位健康和​​醫療設備授權、歐洲法規結構、世界衛生組織（WHO）的醫護人員和老齡化數據、經合組織（OECD）的健康指標、世界銀行的人口和基礎設施數據以及各國數位健康戰略。

結論

虛擬實境技術在醫療領域的應用正進入一個更系統化的階段，其特徵是臨床檢驗、監管審查以及與醫療服務系統的整合。這項技術不再只是實驗性的試點項目，而是逐漸成為身臨其境型治療、醫學模擬、手術視覺化、復原、提升病患參與度的實用工具。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：醫療領域的虛擬實境市場：依組件分類

  • 硬體
  • 服務
  • 軟體

第8章：醫療領域的虛擬實境市場：依產品類型分類

  • Cave System
    • 多層牆
    • 單層壁
  • 手勢追蹤
    • 慣性追蹤
    • 光學追蹤
  • 觸覺回饋
    • 力回饋外骨骼
    • 高保真地球儀
  • 頭戴式顯示器
    • 獨立式耳機
    • 有線耳機

第9章：醫療領域的虛擬實境市場：依交付模式分類

  • 基於雲端的
  • 混合
  • 現場

第10章：醫療領域的虛擬實境市場：依應用分類

  • 診斷
    • 醫學影像診斷
    • 遠端醫療診斷
  • 復原
    • 神經復健
    • 整形外科復健
    • 中風復健
  • 外科手術
    • 腹腔鏡手術
    • 神經外科
    • 整形外科手術
  • 治療
    • 認知復健
    • 物理治療
    • 心理治療
  • 訓練
    • 緊急應變訓練
    • 設備操作培訓
    • 術前培訓

第11章：醫療領域的虛擬實境市場：依最終用戶分類

  • 診所
  • 醫院
  • 醫學院
  • 復健中心

第12章：醫療保健領域的虛擬實境市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：醫療領域的虛擬實境市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：醫療領域的虛擬實境市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • AppliedVR, Inc.
  • BehaVR, LLC
  • CAE Inc.
  • FundamentalVR Ltd.
  • GE HealthCare Technologies Inc.
  • HTC Corporation
  • ImmersiveTouch, Inc.
  • Karuna Labs, Inc.
  • Koninklijke Philips NV
  • Medical Realities Ltd.
  • Medtronic plc
  • Meta Platforms, Inc.
  • Microsoft Corporation
  • MindMaze SA
  • Mynd Immersive, Inc.
  • Osso VR, Inc.
  • Oxford Medical Simulation Ltd.
  • Samsung Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Sony Group Corporation
  • SyncThink, Inc.
  • VirtaMed AG
  • XRHealth USA, Inc.
Product Code: MRR-0315DDADCE12

The Virtual Reality in Healthcare Market is projected to grow by USD 13.80 billion at a CAGR of 13.18% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.80 billion
Estimated Year [2026] USD 6.54 billion
Forecast Year [2032] USD 13.80 billion
CAGR (%) 13.18%

Virtual reality in healthcare is moving from innovation pilots into validated clinical, training, and operational workflows. Hospitals, medical schools, rehabilitation centers, and digital health developers are using immersive healthcare platforms for pain distraction, exposure therapy, surgical planning, physical rehabilitation, clinician training, and patient education. Adoption is supported by stronger clinical evidence generation, lower headset costs, improved spatial computing, and rising demand for scalable clinical capacity.

The strongest near-term adoption is occurring where VR addresses measurable health system constraints: shortages of trained clinicians, the need for repeatable simulation, chronic pain management, anxiety reduction, stroke and musculoskeletal rehabilitation, and remote therapeutic engagement. The U.S. FDA authorization of AppliedVR's RelieVRx for chronic lower back pain marked a significant regulatory milestone for prescription immersive therapeutics, while surgical visualization and simulation platforms continue to gain traction in procedure planning and medical education.

For healthcare executives, the strategic value of virtual reality lies in its ability to combine standardization, personalization, and measurable engagement. When deployed with clinical governance, data protection, infection-control protocols, accessibility standards, and workflow integration, VR can improve training consistency, expand access to therapeutic interventions, and create differentiated patient experiences across the continuum of care.

Transformative Shifts in the VR Healthcare Landscape

The VR healthcare landscape is being reshaped by the convergence of digital therapeutics, spatial computing, telehealth, and simulation-based education. Healthcare providers are increasingly looking beyond entertainment-style VR and prioritizing platforms that support clinical validation, interoperability, patient safety, and measurable outcomes. This shift is accelerating demand for evidence-based VR therapy, immersive medical simulation, and clinician-supervised rehabilitation tools.

A major transformation is the movement from facility-only VR systems to hybrid and home-based care models. Remote therapeutic monitoring codes in the United States, wider acceptance of telehealth, and growing use of connected devices are creating pathways for supervised VR-based rehabilitation, behavioral health, and chronic disease support. At the same time, medical schools and health systems are using immersive simulation to reduce dependence on limited training resources, improve procedural rehearsal, and standardize training across distributed campuses.

Regulation is also redefining competitive advantage. Software-as-a-medical-device expectations, cybersecurity requirements, data privacy laws, medical device quality systems, and post-market surveillance obligations are raising the bar for vendors. Organizations that can demonstrate clinical evidence, usability for diverse patient populations, accessibility, and integration with electronic health records are better positioned than standalone hardware-focused entrants.

Cumulative Impact of Artificial Intelligence on Healthcare VR

Artificial intelligence is expanding the clinical and operational value of virtual reality in healthcare by making immersive experiences more adaptive, measurable, and scalable. AI-enabled VR can personalize therapy intensity, adjust rehabilitation exercises based on performance, analyze user movement, and support clinical decision-making through patient engagement and progress data. In training environments, AI can generate realistic case variations, assess procedural performance, and provide real-time feedback to learners.

Computer vision, natural language processing, and generative AI are particularly relevant. Computer vision can support motion tracking and biomechanics assessment, NLP can enable conversational virtual patients and guided coaching, and generative AI can create scenario-based simulations for emergency care, surgery, mental health, and patient communication training. These capabilities align with the industry's broader move toward adaptive digital therapeutics and competency-based medical education.

The cumulative impact is not simply automation; it is intelligence at the point of immersion. However, AI-enabled VR must be governed carefully. Bias testing, model validation, explainability, patient consent, cybersecurity, and compliance with frameworks such as HIPAA, GDPR, the EU AI Act, and medical device regulations are becoming essential for enterprise-grade adoption.

Key Regional Insights for Healthcare VR Adoption

Asia-Pacific is one of the most dynamic regions for virtual reality in healthcare, driven by Japan's super-aging society, China's smart hospital and digital health investment, India's large-scale healthcare access needs, South Korea's digital therapeutics policy momentum, and Australia's telehealth maturity. The region's adoption is strongest where VR supports rehabilitation, clinician education, remote care, cognitive health, and procedural simulation, although localization, reimbursement clarity, and regulatory requirements vary widely across countries.

North America remains one of the most mature regions for healthcare VR adoption, supported by advanced hospital infrastructure, digital health investment, clinical trial activity, and a clearer regulatory pathway for software-based medical devices. The United States anchors regional demand through academic medical centers, Veterans Health Administration innovation programs, prescription digital therapeutics, and surgical planning adoption, while Canada is expanding VR use in rehabilitation, medical education, and remote care across publicly funded health systems.

Latin America is at an earlier but promising stage, with Brazil and Mexico showing interest in medical training, pain management, patient education, and remote rehabilitation amid persistent healthcare access gaps. Europe is advancing through structured regulation, university-hospital collaboration, and public health digitization; the European Union's Medical Device Regulation, GDPR, and AI Act create a demanding but trusted environment for VR therapy, simulation, and diagnostic-support applications, while the United Kingdom, Germany, France, Italy, and Spain show notable activity in rehabilitation, hospital innovation, and digital care pathways.

The Middle East is investing aggressively in smart hospitals and digital health ecosystems, particularly across the UAE and Saudi Arabia, where national transformation strategies support advanced care models, AI-enabled healthcare, and medical tourism. Africa is more nascent but strategically important, as VR can support workforce training, specialist education, and low-risk procedural simulation where clinical training resources are constrained. Connectivity, affordability, device maintenance, and culturally relevant content remain decisive factors in both Middle Eastern and African adoption.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are increasingly relevant for virtual reality in healthcare because they combine expanding hospital networks, medical tourism, digital health policies, and a young technology workforce. Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines present different adoption profiles, but common opportunities include clinical training, patient education, rehabilitation, and remote specialist support, particularly where immersive simulation can supplement uneven access to experienced trainers.

The GCC is emerging as a high-value demand cluster for immersive healthcare, supported by government-led investments in smart hospitals, AI strategies, virtual care, and medical tourism. Saudi Arabia and the UAE are particularly influential because national health transformation agendas are encouraging advanced diagnostics, digital therapeutics, simulation-based clinical training, and connected hospital infrastructure.

The European Union offers one of the world's most regulated but commercially attractive environments for VR healthcare. Compliance with MDR, GDPR, and the EU AI Act can lengthen market entry, yet it also strengthens trust and procurement readiness. BRICS countries add scale and diversity, with China, India, and Brazil offering large patient populations and unmet healthcare needs, while Russia and South Africa present more selective opportunities shaped by public-sector capacity, infrastructure variability, and procurement constraints.

G7 countries remain central to clinical evidence generation, reimbursement experimentation, research funding, and high-acuity hospital adoption, making them important reference markets for healthcare VR validation. NATO relevance is more specialized but meaningful, as military medicine, trauma preparedness, rehabilitation, and battlefield medical simulation create use cases for VR-based training and recovery tools that can later translate into civilian healthcare.

Key Country Insights for Virtual Reality in Healthcare

The United States is the most influential country environment due to FDA digital health activity, large health system innovation budgets, and adoption of VR for pain management, behavioral health, surgical planning, and medical simulation. Canada is progressing through rehabilitation, academic research, and rural care models, while Mexico is building demand around private hospitals, medical education, and cost-effective specialist training. Brazil leads Latin American potential with large hospital networks, an expanding health technology ecosystem, and regulatory attention to data protection through LGPD.

In Europe, the United Kingdom benefits from NHS digital transformation, university research, and strong interest in mental health and rehabilitation tools. Germany's DiGA framework has helped normalize reimbursed digital therapeutics, creating an important reference point for VR-based clinical software, while France is investing in digital health infrastructure and hospital modernization. Italy and Spain show demand in rehabilitation, aging-related care, and medical education, while Russia's opportunity is more constrained by geopolitical and procurement complexity but remains relevant in domestic simulation and training.

Across Asia-Pacific, China is scaling smart hospitals and digital health applications, making it a major long-term VR opportunity despite regulatory and localization requirements. India offers large-scale potential for training, remote rehabilitation, and affordable immersive education under a rapidly expanding digital health ecosystem. Japan's aging population supports demand for rehabilitation, cognitive health, and care support, while South Korea combines advanced connectivity, device innovation, and digital therapeutics policy momentum. Australia is well positioned for telehealth-linked VR rehabilitation, rural care access, and university-led clinical validation.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated use cases before scaling enterprise deployment. Pain management, rehabilitation, anxiety reduction, surgical planning, and medical simulation offer clearer evidence pathways than broadly defined wellness applications. Vendors should build clinical study programs, publish outcomes, and align product roadmaps with provider workflows rather than relying on novelty-driven adoption.

Health systems should evaluate VR platforms using measurable criteria: clinical efficacy, safety, accessibility, hygiene protocols, device management, cybersecurity, integration with electronic health records, and total cost of ownership. Procurement teams should require evidence aligned with intended use, particularly when VR products claim therapeutic benefit or support clinical decision-making.

Technology providers should design for interoperability, reimbursement readiness, regulatory scalability, and inclusive user experience. Partnerships with hospitals, payers, academic medical centers, rehabilitation networks, and medical schools can accelerate evidence generation. Organizations that combine immersive content, AI-driven personalization, compliant data infrastructure, and clinician-friendly analytics will be best positioned for durable adoption.

Research Methodology

This executive summary is grounded in secondary research across peer-reviewed medical literature, regulatory databases, government health agencies, public health datasets, and verified public disclosures. Sources considered include FDA digital health and medical device authorizations, European regulatory frameworks, WHO health workforce and aging data, OECD health indicators, World Bank demographic and infrastructure data, and national digital health strategies.

The analysis triangulates clinical adoption signals, regulatory momentum, health system demand, technology maturity, reimbursement developments, and regional healthcare infrastructure. Market interpretation focuses on verified use cases rather than speculative applications, with special attention to pain therapy, rehabilitation, behavioral health, surgical planning, medical education, and remote care.

Qualitative assessment was strengthened through cross-comparison of country-level healthcare digitization, privacy rules, medical device requirements, and hospital innovation activity. The methodology emphasizes factual consistency, transparent assumptions, and relevance for executives evaluating investment, partnership, and commercialization strategies in virtual reality healthcare.

Conclusion

Virtual reality in healthcare is entering a more disciplined phase defined by clinical validation, regulatory scrutiny, and integration with care delivery. The technology is no longer limited to experimental pilots; it is becoming a practical tool for immersive therapy, medical simulation, surgical visualization, rehabilitation, and patient engagement.

The next wave of value will come from evidence-backed platforms that combine VR with AI, analytics, remote care infrastructure, and compliant data governance. Regional opportunities will vary, but the underlying drivers are consistent: workforce shortages, aging populations, chronic disease burden, demand for scalable training, and the need for more engaging digital care models.

Organizations that move early with rigorous evidence, strong partnerships, accessibility-focused design, and patient-centered implementation will be positioned to lead as virtual reality becomes an integrated component of modern healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Virtual Reality in Healthcare Market, by Component

  • 7.1. Hardware
  • 7.2. Services
  • 7.3. Software

8. Virtual Reality in Healthcare Market, by Product Type

  • 8.1. Cave System
    • 8.1.1. Multi Wall
    • 8.1.2. Single Wall
  • 8.2. Gesture Tracking
    • 8.2.1. Inertial Tracking
    • 8.2.2. Optical Tracking
  • 8.3. Haptic Feedback
    • 8.3.1. Force Feedback Exoskeleton
    • 8.3.2. High Fidelity Glove
  • 8.4. Head Mounted Display
    • 8.4.1. Standalone Headset
    • 8.4.2. Tethered Headset

9. Virtual Reality in Healthcare Market, by Delivery Mode

  • 9.1. Cloud Based
  • 9.2. Hybrid
  • 9.3. On Premise

10. Virtual Reality in Healthcare Market, by Application

  • 10.1. Diagnostics
    • 10.1.1. Medical Imaging Diagnostics
    • 10.1.2. Telemedicine Diagnostics
  • 10.2. Rehabilitation
    • 10.2.1. Neurological Rehabilitation
    • 10.2.2. Orthopedic Rehabilitation
    • 10.2.3. Stroke Rehabilitation
  • 10.3. Surgery
    • 10.3.1. Laparoscopic Surgery
    • 10.3.2. Neurosurgery
    • 10.3.3. Orthopedic Surgery
  • 10.4. Therapy
    • 10.4.1. Cognitive Rehabilitation
    • 10.4.2. Physical Therapy
    • 10.4.3. Psychological Therapy
  • 10.5. Training
    • 10.5.1. Emergency Response Training
    • 10.5.2. Equipment Handling Training
    • 10.5.3. Preoperative Training

11. Virtual Reality in Healthcare Market, by End User

  • 11.1. Clinics
  • 11.2. Hospitals
  • 11.3. Medical Schools
  • 11.4. Rehabilitation Centers

12. Virtual Reality in Healthcare Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Virtual Reality in Healthcare Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Virtual Reality in Healthcare Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. AppliedVR, Inc.
  • 16.2. BehaVR, LLC
  • 16.3. CAE Inc.
  • 16.4. FundamentalVR Ltd.
  • 16.5. GE HealthCare Technologies Inc.
  • 16.6. HTC Corporation
  • 16.7. ImmersiveTouch, Inc.
  • 16.8. Karuna Labs, Inc.
  • 16.9. Koninklijke Philips N.V.
  • 16.10. Medical Realities Ltd.
  • 16.11. Medtronic plc
  • 16.12. Meta Platforms, Inc.
  • 16.13. Microsoft Corporation
  • 16.14. MindMaze SA
  • 16.15. Mynd Immersive, Inc.
  • 16.16. Osso VR, Inc.
  • 16.17. Oxford Medical Simulation Ltd.
  • 16.18. Samsung Electronics Co., Ltd.
  • 16.19. Siemens Healthineers AG
  • 16.20. Sony Group Corporation
  • 16.21. SyncThink, Inc.
  • 16.22. VirtaMed AG
  • 16.23. XRHealth USA, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CAVE SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CAVE SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CAVE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MULTI WALL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MULTI WALL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MULTI WALL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE WALL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE WALL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE WALL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GESTURE TRACKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GESTURE TRACKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GESTURE TRACKING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INERTIAL TRACKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INERTIAL TRACKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INERTIAL TRACKING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OPTICAL TRACKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OPTICAL TRACKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OPTICAL TRACKING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HAPTIC FEEDBACK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HAPTIC FEEDBACK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HAPTIC FEEDBACK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FORCE FEEDBACK EXOSKELETON MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FORCE FEEDBACK EXOSKELETON MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FORCE FEEDBACK EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIGH FIDELITY GLOVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HIGH FIDELITY GLOVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIGH FIDELITY GLOVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HEAD MOUNTED DISPLAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEAD MOUNTED DISPLAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEAD MOUNTED DISPLAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL STANDALONE HEADSET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STANDALONE HEADSET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STANDALONE HEADSET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TETHERED HEADSET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TETHERED HEADSET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TETHERED HEADSET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CLOUD BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CLOUD BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CLOUD BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HYBRID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HYBRID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HYBRID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ON PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ON PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ON PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL IMAGING DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL IMAGING DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL IMAGING DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TELEMEDICINE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TELEMEDICINE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TELEMEDICINE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEUROLOGICAL REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROLOGICAL REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROLOGICAL REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ORTHOPEDIC REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ORTHOPEDIC REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ORTHOPEDIC REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL STROKE REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL STROKE REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL STROKE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LAPAROSCOPIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL LAPAROSCOPIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL LAPAROSCOPIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROSURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEUROSURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL COGNITIVE REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL COGNITIVE REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL COGNITIVE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHYSICAL THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PHYSICAL THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHYSICAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PSYCHOLOGICAL THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PSYCHOLOGICAL THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PSYCHOLOGICAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TRAINING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL TRAINING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL TRAINING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL EMERGENCY RESPONSE TRAINING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL EMERGENCY RESPONSE TRAINING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL EMERGENCY RESPONSE TRAINING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL EQUIPMENT HANDLING TRAINING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL EQUIPMENT HANDLING TRAINING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL EQUIPMENT HANDLING TRAINING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PREOPERATIVE TRAINING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PREOPERATIVE TRAINING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PREOPERATIVE TRAINING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL SCHOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL SCHOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL SCHOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 239. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 241. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 242. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 243. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 244. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 245. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 248. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 249. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 250. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 251. GCC VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 284. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 286. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 287. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 288. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 289. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 290. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 292. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 293. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 294. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 295. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 296. G7 VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 299. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 301. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 302. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 303. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 304. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 305. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 307. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 308. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 309. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 310. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 311. NATO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. GLOBAL VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED STATES VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 330. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY CAVE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 332. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY GESTURE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 333. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HAPTIC FEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 334. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY HEAD MOUNTED DISPLAY, 2018-2032 (USD MILLION)
  • TABLE 335. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 336. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 337. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 338. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 339. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY SURGERY, 2018-2032 (USD MILLION)
  • TABLE 340. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
  • TABLE 341. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY TRAINING, 2018-2032 (USD MILLION)
  • TABLE 342. CANADA VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. MEXICO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 344. MEXICO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 345. MEXICO VIRTUAL REALITY IN HEALTHCARE MARKET SIZE, BY PRODUCT